study sample analysis [Bioanalytics]

posted by Falisa_Mustafa – Malaysia, 2012-01-20 05:06 (4881 d 08:12 ago) – Posting: # 7969
Views: 2,820

hi,

i would like to seek some advice regarding the analysis of study sample from regulatory point of view.

scientifically, would it be acceptable to not analyze all study samples from a in a single run (i.e multiple runs) as long as the bioanalytical method has completely been validated and documented acceptable inter-assay variability?.
is there any justification behind the acceptance of single / multiple run(s) analysis results?

is there any references/guidelines that i can refer to regarding this matter?

thanx!

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
13 visitors (0 registered, 13 guests [including 3 identified bots]).
Forum time: 14:18 CEST (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5